Ulrich Mahlknecht Selected Research

Ulrich Mahlknecht Research Topics

Disease

19	Neoplasms (Cancer) 01/2016 - 07/2003
5	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 09/2020 - 10/2007
5	Melanoma (Melanoma, Malignant) 01/2016 - 11/2006
3	Carcinogenesis 10/2011 - 12/2004
2	Breast Neoplasms (Breast Cancer) 01/2013 - 12/2011
2	Metabolic Diseases (Metabolic Disease) 09/2010 - 11/2008
2	Hematologic Neoplasms (Hematological Malignancy) 11/2008 - 11/2008
2	Leukemia 10/2007 - 12/2006
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 10/2007 - 01/2005
1	Neuroblastoma 05/2014
1	Lymphoma (Lymphomas) 01/2013
1	Thrombocytopenia (Thrombopenia) 10/2012
1	Hemorrhage 10/2012
1	Hepatitis C 12/2011
1	Neoplasm Metastasis (Metastasis) 10/2011
1	Chronic Disease (Chronic Diseases) 01/2010
1	Neurodegenerative Diseases (Neurodegenerative Disease) 11/2008
1	Myeloid Leukemia (Leukemia, Myelocytic) 09/2008
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 09/2008
1	Acquired Immunodeficiency Syndrome (AIDS) 03/2008
1	Residual Neoplasm 03/2008
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2008
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 10/2007
1	Brain Neoplasms (Brain Tumor) 11/2005
1	Nervous System Diseases (Neurological Disorders) 07/2003

Drug/Important Bio-Agent (IBA)

9	Histone Deacetylase InhibitorsIBA 05/2014 - 12/2004
6	Proteins (Proteins, Gene)FDA Link 09/2020 - 07/2003
5	DNA (Deoxyribonucleic Acid)IBA 01/2016 - 09/2008
4	MethyltransferasesIBA 05/2013 - 09/2008
4	SirtuinsIBA 12/2010 - 02/2008
3	MicroRNAs (MicroRNA)IBA 01/2013 - 10/2011
3	Azacitidine (5 Azacytidine)FDA Link 01/2012 - 09/2008
2	Estrogen Receptor alphaIBA 01/2016 - 01/2013
2	CurcuminIBA 05/2014 - 01/2013
2	Messenger RNA (mRNA)IBA 01/2012 - 07/2003
2	Sirtuin 3IBA 03/2011 - 09/2010
2	Sirtuin 1IBA 11/2008 - 02/2008
2	Valproic Acid (Depakote)FDA LinkGeneric 03/2008 - 01/2008
2	Vorinostat FDA Link 03/2008 - 01/2005
1	multidrug resistance-associated protein 1IBA 09/2020
1	Trastuzumab (Herceptin)FDA Link 01/2016
1	SteroidsIBA 01/2013
1	Progesterone Receptors (Progesterone Receptor)IBA 01/2013
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 01/2013
1	Polysaccharides (Glycans)IBA 01/2013
1	Hormones (Hormone)IBA 01/2013
1	Cytarabine (Cytosar-U)FDA LinkGeneric 05/2012
1	Cytostatic AgentsIBA 05/2012
1	Calcitriol (Calcijex)FDA LinkGeneric 01/2012
1	theasinensin AIBA 01/2012
1	trichostatin A (A 300)IBA 01/2012
1	Vitamin D FDA LinkGeneric 01/2012
1	Calcitriol Receptors (Calcitriol Receptor)IBA 01/2012
1	1,25-dihydroxyvitamin DIBA 01/2012
1	Tamoxifen FDA LinkGeneric 12/2011
1	Estrogens (Estrogen)FDA Link 12/2011
1	Ribavirin (Virazole)FDA LinkGeneric 12/2011
1	ElementsIBA 09/2010
1	Decitabine FDA Link 09/2008
1	Human Immunodeficiency Virus nef Gene ProductsIBA 03/2008
1	Integrin alpha4beta1 (VLA-4)IBA 03/2008
1	Mitogen-Activated Protein KinasesIBA 10/2007
1	rocaglamideIBA 10/2007
1	p38 Mitogen-Activated Protein KinasesIBA 10/2007
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 10/2007
1	Cycloheximide (Cicloheximide)IBA 12/2006
1	wogoninIBA 12/2006
1	Protein Synthesis InhibitorsIBA 12/2006
1	NF-kappa B (NF-kB)IBA 12/2006
1	Free RadicalsIBA 12/2006
1	Dactinomycin (Actinomycin)FDA LinkGeneric 12/2006
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2006
1	Interferon-betaIBA 11/2006
1	InterferonsIBA 11/2006
1	Sirtuin 2IBA 11/2005
1	bcr-abl Fusion ProteinsIBA 01/2005
1	Histones (Histone)IBA 12/2004
1	Oxygen (Dioxygen)IBA 10/2003

Therapy/Procedure

5	Drug Therapy (Chemotherapy) 01/2016 - 10/2007
2	Therapeutics 01/2016 - 10/2011
1	Stem Cell Transplantation 10/2012
1	Platelet Transfusion (Blood Platelet Transfusions) 10/2012
1	Radiotherapy 01/2010